FR2502008A1 - Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes - Google Patents
Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes Download PDFInfo
- Publication number
- FR2502008A1 FR2502008A1 FR8105487A FR8105487A FR2502008A1 FR 2502008 A1 FR2502008 A1 FR 2502008A1 FR 8105487 A FR8105487 A FR 8105487A FR 8105487 A FR8105487 A FR 8105487A FR 2502008 A1 FR2502008 A1 FR 2502008A1
- Authority
- FR
- France
- Prior art keywords
- vitamin
- gum
- pref
- ammoniac
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000011782 vitamin Substances 0.000 title claims description 6
- 235000013343 vitamin Nutrition 0.000 title claims description 6
- 229930003231 vitamin Natural products 0.000 title claims description 6
- 229940088594 vitamin Drugs 0.000 title claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 title claims description 6
- 229940095054 ammoniac Drugs 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241001096899 Ferula ammoniacum Species 0.000 claims abstract description 3
- 241001251026 Ferula aucheri Species 0.000 claims abstract description 3
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 3
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 3
- 239000011718 vitamin C Substances 0.000 claims abstract description 3
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 3
- 239000011712 vitamin K Substances 0.000 claims abstract description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 241000208173 Apiaceae Species 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 238000011282 treatment Methods 0.000 abstract description 9
- 238000011321 prophylaxis Methods 0.000 abstract description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract description 2
- 208000000668 Chronic Pancreatitis Diseases 0.000 abstract description 2
- 206010033649 Pancreatitis chronic Diseases 0.000 abstract description 2
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 2
- 208000006673 asthma Diseases 0.000 abstract description 2
- 208000000718 duodenal ulcer Diseases 0.000 abstract description 2
- 208000006454 hepatitis Diseases 0.000 abstract description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract description 2
- 230000000552 rheumatic effect Effects 0.000 abstract description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 3
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8105487A FR2502008A1 (fr) | 1981-03-19 | 1981-03-19 | Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8105487A FR2502008A1 (fr) | 1981-03-19 | 1981-03-19 | Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2502008A1 true FR2502008A1 (fr) | 1982-09-24 |
| FR2502008B1 FR2502008B1 (OSRAM) | 1983-11-25 |
Family
ID=9256414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8105487A Granted FR2502008A1 (fr) | 1981-03-19 | 1981-03-19 | Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2502008A1 (OSRAM) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2668062A1 (fr) * | 1990-10-22 | 1992-04-24 | Chekroun Mehir | Composition dermatologique et ou cosmetiques comprenant de la gomme amoniaque et un extrait de graisses de peganum harmalis. |
| WO2001052824A3 (de) * | 2000-01-17 | 2002-03-07 | Morphochem Ag | Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c |
| US8722109B1 (en) | 2013-03-12 | 2014-05-13 | Abdul-Wahab Fahad Al-Shemmeri | Composition comprising plant extracts and essential oils |
-
1981
- 1981-03-19 FR FR8105487A patent/FR2502008A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| EXBK/58 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2668062A1 (fr) * | 1990-10-22 | 1992-04-24 | Chekroun Mehir | Composition dermatologique et ou cosmetiques comprenant de la gomme amoniaque et un extrait de graisses de peganum harmalis. |
| WO1992006673A1 (fr) * | 1990-10-22 | 1992-04-30 | Mehir Chekroun | Compositions dermatologiques et/ou cosmetiques comprenant de la gomme ammoniaquee et un extrait de graines de peganum harmalis |
| WO2001052824A3 (de) * | 2000-01-17 | 2002-03-07 | Morphochem Ag | Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c |
| US8722109B1 (en) | 2013-03-12 | 2014-05-13 | Abdul-Wahab Fahad Al-Shemmeri | Composition comprising plant extracts and essential oils |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2502008B1 (OSRAM) | 1983-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mangaiyarkarasi et al. | Benefits of Aloe vera in dentistry | |
| Haffajee et al. | Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections | |
| Ainamo et al. | Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis | |
| Dodwad et al. | Propolis mouthwash: A new beginning | |
| De Vree et al. | Periodontal treatment of rapid progressive periodontitis in 2 siblings with Papillon‐Lefèvre syndrome: 15‐year follow‐up | |
| Hattarki et al. | Evaluation of the efficacy of green tea catechins as an adjunct to scaling and root planing in the management of chronic periodontitis using PCR analysis: A clinical and microbiological study | |
| Kaplan et al. | Helicobacter pylori treatment in Turkey: Current status and rational treatment options | |
| FR2711528A1 (fr) | Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose. | |
| Pasquier et al. | “Hemicrania continua”: the first bilateral case? | |
| Murugesan et al. | A comparative study of synbiotic as an add-on therapy to standard treatment in patients with aggressive periodontitis | |
| Krishna et al. | Health from the hive: 5% Propolis mouth wash as an adjunct in the treatment of chronic generalized gingivitis-a randomized controlled clinical trial | |
| Limongelli et al. | Nomalike lesion in a patient with chronic lymphocytic leukemia: review of the literature and report of a case | |
| Nguyen et al. | Evaluation of lozenges containing egg yolk antibody against Porphyromonas gingivalis gingipains as an adjunct to conventional non‐surgical therapy in periodontitis patients: A randomized controlled clinical trial | |
| Kitagawa et al. | Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7, 12-dimethylbenz [a] anthracene in rats on high-and low-fat diets | |
| FR2502008A1 (fr) | Composition pharmaceutique a base de gomme ammoniaque utile dans le traitement de diverses maladies et application de cette composition au traitement de tumeurs malignes | |
| Wu et al. | Higher frequencies of anemia, hematinic deficiencies, and gastric parietal cell antibody positivity in vitamin B12-deficient Taiwanese male oral submucous fibrosis patients | |
| Miguel et al. | Influence of iron alone or with fluoride on caries development in desalivated and intact rats | |
| Wu et al. | Higher frequencies of anemia, vitamin B12 deficiency, and gastric parietal cell antibody positivity in folic acid-deficient Taiwanese male oral submucous fibrosis patients | |
| FR2641189A1 (fr) | Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6 | |
| US3560612A (en) | Method of alleviating hypercitricemia | |
| Gaby | Natural remedies for scleroderma | |
| WO1987003810A1 (fr) | Compositions nutritionnelles carencees en methionine et supplementee en homocysteine | |
| Hoeltl et al. | How Effective is Topical Alpha‐2b Interferon in Preventing Recurrence of Superficial Bladder Cancer? | |
| Mahdi | Comparative Effect of Topical Tacrolimus and Topical Isotretinoin in Patients with Oral Lichen Planus. | |
| Rogers et al. | Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma |